3ftk: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: '''Unreleased structure''' The entry 3ftk is ON HOLD Authors: Wiltzius, Jed J.W., Sawaya, Michael R., Eisenberg, D. Description: NVGSNTY segment from Islet Amyloid Polypeptide (IAPP or...
 
OCA (talk | contribs)
No edit summary
 
(12 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 3ftk is ON HOLD
==NVGSNTY segment from Islet Amyloid Polypeptide (IAPP or Amylin), hydrated crystal form==
 
<StructureSection load='3ftk' size='340' side='right'caption='[[3ftk]], [[Resolution|resolution]] 1.50&Aring;' scene=''>
Authors: Wiltzius, Jed J.W., Sawaya, Michael R., Eisenberg, D.
== Structural highlights ==
 
<table><tr><td colspan='2'>[[3ftk]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FTK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3FTK FirstGlance]. <br>
Description: NVGSNTY segment from Islet Amyloid Polypeptide (IAPP or Amylin), hydrated crystal form
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.5&#8491;</td></tr>
 
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ftk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ftk OCA], [https://pdbe.org/3ftk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ftk RCSB], [https://www.ebi.ac.uk/pdbsum/3ftk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ftk ProSAT]</span></td></tr>
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 21 10:40:07 2009''
</table>
== Function ==
[https://www.uniprot.org/uniprot/IAPP_HUMAN IAPP_HUMAN] Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism.
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Eisenberg D]]
[[Category: Sawaya MR]]
[[Category: Wiltzius JJW]]